Nyx Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.46%
- Profit Growth 4.58%
- Ebitda -269.13%
- Net Worth 21.97%
- Total Assets 70.76%
About Nyx Pharmaceuticals
Nyx Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 2019 (Five years and six months 11 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravneet Singh, Harsimran Kalra, Ashok Kumar, and Two other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909CH2019PTC042632
- Company No.
042632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Nyx Pharmaceuticals Private Limited offer?
Nyx Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Fertilizers and Soil Additives, Sulfur Fertilizers, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Fitness Supplements, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Nyx Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravneet Singh  | Director | 22-Jul-2019 | Current |
| Harsimran Kalra | Director | 22-Jul-2019 | Current |
| Ashok Kumar | Director | 22-Jul-2019 | Current |
| Gaurav Gabbi | Director | 22-Jul-2019 | Current |
| Jitender Kalra | Director | 23-Aug-2019 | Current |
Financial Performance of Nyx Pharmaceuticals.
Nyx Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 100.46% increase. The company also saw a slight improvement in profitability, with a 4.58% increase in profit. The company's net worth Soared by an impressive increase of 21.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nyx Pharmaceuticals?
Unlock access to Nyx Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Systole Remedies Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Janus Biotech India Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Burgeon Health Series Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Flanca Life Sciences Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nyx Pharmaceuticals?
Unlock and access historical data on people associated with Nyx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyx Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.